Latest filing published 09 Jun 2011 for BIOSPECIFICS TECHNOLOGIES CORP, €83k.
Insider track record
No signal scores available.
Matthew Geller: trading record in brief
Matthew Geller discloses dealings in Biospecifics Technologies Corp to SEC (Form 4). Over a trading history stretching from 15 April 2010 to 7 June 2011, the count stands at 8 filings.
On the market, this insider has only sold: 6 sales, €505k in total. Outside the open market, there are 2 option exercises. 2011 to date brings no purchases and 6 sales.
Most recently, on 9 June 2011, the filings show an open-market sale worth €83k in Biospecifics Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Geller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$24.23Common Stock, $0.001 par valueSEC:0001062993-11-002527:0
- 5,000 shares@ US$24.57Common Stock, $0.001 par valueSEC:0001062993-11-002527:1
- 7,700 shares@ US$24.08Common StockSEC:0001062993-11-002388:0
- 400 shares@ US$24.18Common StockSEC:0001062993-11-002347:0
- 10,000 shares@ US$24.01Common StockSEC:0001062993-11-002347:1
- 1,900 shares@ US$24.00Common StockSEC:0001062993-11-002347:2
- 15,000 shares@ US$19.00Common StockSEC:0001062993-10-001255:0
7 of 7 declarations